1696 — Sisram Medical Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapContrarian

Annual income statement for Sisram Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	294	354	359	349	365
Cost of Revenue
Gross Profit	167	202	220	217	215
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	250	308	319	314	334
Operating Profit	44	46.7	40	35	31.6
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	41.7	44.2	37.1	32.5	28.6
Provision for Income Taxes
Net Income After Taxes	32.5	40.1	32.9	28.8	25
Minority Interest
Net Income Before Extraordinary Items
Net Income	31.2	40.2	31.5	25.1	19
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	31.2	40.2	31.5	25.1	19
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.069	0.086	0.067	0.046	0.041
Dividends per Share